Plump Andrew Stewart
President, R&D
Plump Andrew Stewart has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Sep 4, 2026.
On the most recent filing, Plump Andrew Stewart is listed as President, R&D at TAKEDA PHARMACEUTICAL CO LTD. Inside the rolling window, Plump Andrew Stewart reported no open-market purchases and 3 open-market sales totaling $5.3M in TAK. The largest disclosed transaction in the window is a sale of 165,393 TAK shares on Aug 10, 2026, worth $2.8M.
Companies traded
Other insiders at TAK
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$5.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Plump Andrew Stewart made?
Plump Andrew Stewart has filed 5 SEC Form 4 filings (5 transaction rows) across 1 company since 2026.
Which companies does Plump Andrew Stewart trade?
Plump Andrew Stewart has filed SEC Form 4 disclosures for 1 company, including TAK.
When was Plump Andrew Stewart's most recent SEC Form 4 filing?
Plump Andrew Stewart's most recent SEC Form 4 filing on Tracefour is dated Sep 4, 2026.
What is Plump Andrew Stewart's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Plump Andrew Stewart is listed as President, R&D.
What is Plump Andrew Stewart's total buy and sell value in the current window?
Inside the rolling retention window, Plump Andrew Stewart bought $0 and sold $5.3M based on SEC Form 4 filings.
What was Plump Andrew Stewart's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 165,393 TAK shares on 2026-08-10, worth $2.8M, per SEC Form 4 filings.